DC
Decheng Capital Portfolio holdings
AUM
$396M
This Quarter Return
+33.11%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$358M
AUM Growth
–
Cap. Flow
+$358M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
84.63%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$135M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$31.8M |
| 3 |
Pacific Biosciences
PACB
|
$28.8M |
| 4 |
10x Genomics
TXG
|
$20.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$19.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
1
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $135M | 37.72% | +7,083,288 | New | +$135M |
|
|
2
Zentalis Pharmaceuticals
ZNTL
$122M
| $31.8M | 8.89% | +2,099,583 | New | +$31.8M |
|
|
3
Pacific Biosciences
PACB
$393M
| $28.8M | 8.06% | +2,940,361 | New | +$28.8M |
|
|
4
10x Genomics
TXG
$1.74B
| $20.1M | 5.62% | +359,554 | New | +$20.1M |
|
|
IMGN
5
DELISTED
Immunogen Inc
IMGN
| $19.6M | 5.47% | +659,928 | New | +$19.6M |
|
6
Arcus Biosciences
RCUS
$1.13B
| $16.6M | 4.64% | +869,790 | New | +$16.6M |
|
|
KRTX
7
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $14.9M | 4.16% | +47,000 | New | +$14.9M |
|
8
Roivant Sciences
ROIV
$8.15B
| $14.4M | 4.02% | +1,279,700 | New | +$14.4M |
|
9
Illumina
ILMN
$15.8B
| $11.3M | 3.15% | +80,859 | New | +$11.3M |
|
10
argenx
ARGX
$43.6B
| $10.4M | 2.92% | +27,429 | New | +$10.4M |
|
|
SLRN
11
DELISTED
ACELYRIN
SLRN
| $10.2M | 2.86% | +1,370,951 | New | +$10.2M |
|
12
Krystal Biotech
KRYS
$4.27B
| $8.16M | 2.28% | +65,772 | New | +$8.16M |
|
13
Phathom Pharmaceuticals
PHAT
$864M
| $7.76M | 2.17% | +850,000 | New | +$7.76M |
|
14
Lantheus
LNTH
$3.73B
| $5.72M | 1.6% | +92,196 | New | +$5.72M |
|
15
Terns Pharmaceuticals
TERN
$609M
| $4.64M | 1.3% | +714,285 | New | +$4.64M |
|
16
Aura Biosciences
AURA
$389M
| $4.57M | 1.28% | +515,555 | New | +$4.57M |
|
17
BeyondSpring
BYSI
$69.4M
| $4.45M | 1.24% | +4,958,143 | New | +$4.45M |
|
18
Equillium
EQ
$62.2M
| $3.22M | 0.9% | +4,447,308 | New | +$3.22M |
|
19
AtriCure
ATRC
$1.84B
| $1.65M | 0.46% | +46,259 | New | +$1.65M |
|
|
HLTH
20
DELISTED
Cue Health Inc. Common Stock
HLTH
| $1.46M | 0.41% | +8,980,909 | New | +$1.46M |
|
21
SCYNEXIS
SCYX
$34.9M
| $1.24M | 0.35% | +555,555 | New | +$1.24M |
|
|
WHWK
22
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.06M | 0.3% | +526,329 | New | +$1.06M |
|
23
Pyxis Oncology
PYXS
$79.4M
| $588K | 0.16% | +326,810 | New | +$588K |
|
24
GeneDx Holdings
WGS
$3.72B
| $285K | 0.08% | +103,604 | New | +$285K |
|